Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas
Nissim Haim(Technion – Israel Institute of Technology), Eliezer Robinson, David Yarnitsky(Rappaport Family Institute for Research in the Medical Sciences), Waleed Simri(Technion – Israel Institute of Technology), Ron Epelbaum(University of Bern), Menachem Ben-Shahar(Technion – Israel Institute of Technology)
Cited by 114
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279